NCT02055365View on ClinicalTrials.gov

Pilot Study: Gene Expression Profiling of Immune Response to HBV Vaccination in Healthy Volunteers

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 18, 2014

Primary Completion Date

January 6, 2015

Study Completion Date

January 6, 2015

Conditions
Hepatitis B
Interventions
BIOLOGICAL

Hepatitis B Vaccine (Recombinant)

All subjects will receive the standard 3-dose course of Recombivax HB (Merck) - Hepatitis B Vaccine (Recombinant).

Trial Locations (1)

10065

The Rockefeller University, New York

All Listed Sponsors
lead

Rockefeller University

OTHER

NCT02055365 - Pilot Study: Gene Expression Profiling of Immune Response to HBV Vaccination in Healthy Volunteers | Biotech Hunter | Biotech Hunter